Kevin from Inside China Business reported that the G7 aims to reduce reliance on China for rare earth metals, targeting less than 60% by 2030, focusing...
China views the U.S. as its main geopolitical rival, highlighting Washington’s allies, particularly Japan and the Philippines, in South China Sea military activities. Analysts suggest increasing...
China’s AI-driven drug firms are expanding globally despite U.S. scrutiny. They secured $93 billion in licensing deals in 2026, a significant rise. Metis TechBio struck a...